Patents by Inventor Ren-Huang Wu

Ren-Huang Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Humanized anti-human neurotensin receptor 1 antibodies and their uses
    Patent number: 12091454
    Abstract: A humanized anti-neurotensin receptor 1 (NTSR1) antibody or an antigen-binding fragment thereof. Also, a method for treating, prophylactic treating and/or preventing diseases and/or disorders caused by or related to NTSR1 activity and/or signaling, and a method or kit for detecting NTSR1 in a sample.
    Type: Grant
    Filed: December 28, 2022
    Date of Patent: September 17, 2024
    Assignees: DEVELOPMENT CENTER FOR BIOTECHNOLOGY, NATIONAL HEALTH RESEARCH INSTITUTES
    Inventors: Cheng-Chou Yu, Shu-Ping Yeh, Chao-Yang Huang, Szu-Liang Lai, Shih-Liang Hsiao, Mei-Ling Hou, Tzung-Jie Yang, Wei-Ting Sun, Liang-Yu Hsia, Andrew Yueh, Chiung-Tong Chen, Ren-Huang Wu, Pei-Shan Wu, Han-Shu Hu, Tzu-Chin Wu, Jia-Ni Tian
  • HUMANIZED ANTI-HUMAN NEUROTENSIN RECEPTOR 1 ANTIBODIES AND THEIR USES
    Publication number: 20240218062
    Abstract: A humanized anti-neurotensin receptor 1 (NTSR1) antibody or an antigen-binding fragment thereof. Also, a method for treating, prophylactic treating and/or preventing diseases and/or disorders caused by or related to NTSR1 activity and/or signaling, and a method or kit for detecting NTSR1 in a sample.
    Type: Application
    Filed: December 28, 2022
    Publication date: July 4, 2024
    Applicants: DEVELOPMENT CENTER FOR BIOTECHNOLOGY, NATIONAL HEALTH RESEARCH INSTITUTES
    Inventors: CHENG-CHOU YU, SHU-PING YEH, CHAO-YANG HUANG, SZU-LIANG LAI, SHIH-LIANG HSIAO, MEI-LING HOU, TZUNG-JIE YANG, WEI-TING SUN, LIANG-YU HSIA, ANDREW YUEH, CHIUNG-TONG CHEN, REN-HUANG WU, PEI-SHAN WU, HAN-SHU HU, TZU-CHIN WU, JIA-NI TIAN
  • ANTI-HUMAN NEUROTENSIN RECEPTOR 1 ANTIBODY AND USE THEREOF
    Publication number: 20230183357
    Abstract: An isolated antibody, comprising: a heavy chain variable domain (VH) that is at least 75% identical to the amino acid sequence of SEQ ID NO: 1; and a light chain variable domain (VL) that is at least 75% identical to the amino acid sequence of SEQ ID NO: 2; wherein the antibody binds specifically to human neurotensin receptor 1 (hNTSR1).
    Type: Application
    Filed: June 9, 2021
    Publication date: June 15, 2023
    Inventors: Chuan Shih, Andrew Yueh, Ren-Huang Wu, Han-Shu Hu, Pei-Shan Wu, Zhi-Ping Yang, Yi-Yu Ke, Chiung-Tong Chen